Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Hyperfine Inc (HYPR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Hyperfine's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.800 +0.013    +1.70%
03/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.810
+0.010
+1.250%
22:25:31 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 134,639
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.775 - 0.820
Hyperfine 0.800 +0.013 +1.70%

Hyperfine Inc Company Profile

 
Get an in-depth profile of Hyperfine Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

136

Equity Type

ORD

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Contact Information

Address 351 New Whitfield Street
Guilford, 06437
United States
Phone 866 796 6767
Fax -

Top Executives

Name Age Since Title
Avi Daniel Horev 46 2021 Director
Christopher Jon Gaulin 46 - CEO & Director
Michael Modic - - Member of Medical Advisory Board
Shahid Nimjee - - Member of Medical Advisory Board
Jonathan M. Rothberg 60 2014 Founder & Vice Chairman
Brian Litt - - Member of Medical Advisory Board
Daniel Joseph Wolterman 67 2021 Independent Director
Fady T. Charbel - - Member of Medical Advisory Board
Murat Gunel - - Member of Medical Advisory Board
Eliot L. Siegel - - Member of Advisory Board
R. Scott Huennekens 60 2021 Executive Chairman
Michael Brant-Zawadzki - - Member of Medical Advisory Board
John T. Dahldorf 67 2021 Independent Director
Maria Sainz 58 2021 CEO, President & Director
Roderic Ivan Pettigrew - - Member of Medical Advisory Board
Michael Schulder - - Member of Medical Advisory Board
Ruth Ann Fattori 72 2021 Independent Director
James Smirniotopoulos - - Member of Medical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HYPR Comments

Write your thoughts about Hyperfine Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email